The Polynucleotide Is Encapsidated Within A Bacteriophage, Bacteriophage Coat, Or Transducing Particle Patents (Class 435/472)
-
Publication number: 20030017600Abstract: The present invention is related to a nucleic acid construct (1) to be incorporated in a double selection vector (2) able to transform a cell (3) of a specific organism, wherein—said construct (1) contains two different genes (10 and 11), each gene encoding a different toxic molecule (4 and 5) to a prokaryote cell, preferably to E. Coli, said genes (10 and 11) being disposed upstream and downstream a cassette sequence (8), or downstream and upstream site(s) for the insertion of a cassette sequence (8), and—said nucleic acid construct comprises specific sequence portions (12, 12′) allowing inactivation of said genes (10 and 11).Type: ApplicationFiled: June 20, 2002Publication date: January 23, 2003Inventors: Philippe Gabant, Claude Szpirer
-
Patent number: 6500611Abstract: An innovative detection system for detecting small numbers of target analytes is disclosed. This system provides a novel method for attaching multiple copies of reporter groups to a single site on an analyte of interest. This system preferably comprises a virus capsid enclosing multiple detectable reporter groups, and a linking molecule which is capable of linking the capsid to the analyte of interest.Type: GrantFiled: August 17, 2001Date of Patent: December 31, 2002Inventor: Thomas L. Mattson
-
Publication number: 20020187541Abstract: A novel recombinant Bacillus bacterial strain is constructed by genetic engineering which has high productivity of alpha-amylase. The Bacillus strain comprising an alpha-amylase gene inserted in the Bacillus chromosome under transcriptional control of a phage promoter. An efficient process for the rapid production of large amounts of alpha-amylase is also disclosed.Type: ApplicationFiled: August 7, 2002Publication date: December 12, 2002Applicant: The Hong Kong Polytechnic UniversityInventors: Yun Chung Leung, Wai Hung Lo, Jeffery Errington
-
Patent number: 6482632Abstract: The present invention provides a isolated bacteriophage useful as a tool for studying biological, biochemical, physiological and genetic properties of actinomycetes and other organisms which comprises a novel strain of Saccharomonospora having certain specified characteristics. The invention also relates to a process for the isolation of the said bacteriophage and/or DNA phage and to a novel universal growth medium which is particularly useful in the said process. Another embodiment of the process relates to a cloning vector which comprises a plasmid or bacteriophage comprising the phage DNA of the invention.Type: GrantFiled: April 21, 1999Date of Patent: November 19, 2002Assignee: Council of Scientic and Industrial ResearchInventors: Pushpa Agrawal, Vishal Soni
-
Publication number: 20020146827Abstract: A modified filamentous phage that contains a gene for a wild type phage coat protein and a gene for a synthetic phage coat protein is provided. Uses of the modified phage and kits containing the phage are also provided.Type: ApplicationFiled: November 27, 2001Publication date: October 10, 2002Inventor: Angray S. Kang
-
Publication number: 20020039765Abstract: The present invention relates to transport proteins, in particular VP22 and homologues thereof, and to methods of delivering these proteins and any associated molecules to a target population of cells. This transport protein has applications in gene therapy and methods of targeting agents to cells where targeting oat high efficiency is required.Type: ApplicationFiled: January 31, 2001Publication date: April 4, 2002Inventors: Peter Francis Joseph O'Hare, Gillian Daphne Elliott
-
Patent number: 6338846Abstract: A recombinant baculovirus, which produces a recombinant polyhedra made up of a baculovirus polyhedrin (PH), a Bacillus thuringiensis crystal protein (CP) and jellyfish Aequorea victoria green fluorescent protein (GFP), is constructed by introducing a transfer vector carrying a fusion gene encoding a fusion protein in which the PH, the CP and the GFP are directly linked from N-terminal to C-terminal, in sequence, and a wild-type baculovirus into an insect cell, simultaneously, and culturing the cell. This baculovirus transfer vector pColorBtrus is constructed by synthesizing the GFP-coding DNA fragment from plasmid pGFP, the PH gene from wild-type Autographa californica Nucleopolyhedrovirus, and a Cry1Ac gene from plasmid pPN6.Type: GrantFiled: November 6, 1998Date of Patent: January 15, 2002Inventors: Seok-Kwon Kang, Yeon-Ho Je, Byung-Rae Jin, Hyun-Woo Park, Jong-Yul Roh, Jin-Hee Chang
-
Patent number: 6335185Abstract: The present invention relates to methods for the generation of lambda (&lgr;) or P1 bacteriophage vectors useful in targeted mutagenesis of eukaryotic cells and the expression of genes and proteins, methods for the identification of a &lgr; or P1 bacteriophage vector having a desired nucleic acid from an assortment or library of bacteriophage each having a different nucleic acid insert and the use of such vectors in gene targeting and the expression of genes and protein.Type: GrantFiled: February 2, 1999Date of Patent: January 1, 2002Assignee: University Technologies International Inc.Inventors: Derrick E. Rancourt, Teruhisa Tsuzuki
-
Patent number: 6319716Abstract: The present invention provides the complete nucleotide sequence of a bovine adenovirus. The invention further provides bovine adenovirus vectors and expression systems which can be used, among other things, for insertion of foreign sequences, for provision of DNA control sequences including transcriptional and translational regulatory sequences, for diagnostic purposes to detect the presence of viral nucleic acids or proteins encoded by these regions in a subject or biological sample, for provision of immunogenic polypeptides or fragments thereof, for vaccines and for gene therapy. Cell lines comprising the vectors of the invention, and methods for making bovine adenovirus vectors are also provided.Type: GrantFiled: June 23, 1998Date of Patent: November 20, 2001Assignee: University of SaskatchewanInventors: Suresh Kumar Tikoo, Lorne A. Babiuk, Police Seshidhar Reddy, Alexandre Zakhartchouk, Mohit Baxi
-
Patent number: 6312939Abstract: DNA encoding a therapeutically suitable glutaminase has been molecularly cloned. This allows one to obtain a polypeptide which is a therapeutically suitable glutaminase free of contaminating endotoxin. It has been found that this polypeptide is a potent anti-viral agent and when coupled to an anti-tumor monoclonal antibody is a potent anti-cancer agent. The glutaminase of the present invention is particularly useful for treating lung, breast and colon cancer cells and in the treatment of HIV-infected cells.Type: GrantFiled: April 25, 1995Date of Patent: November 6, 2001Assignee: ME Medical Enzymes AGInventors: Joseph Roberts, Thomas W MacAllister, Natarajan Sethuraman, Abbie G. Freeman
-
Publication number: 20010034043Abstract: This invention is directed to Flavobacterium heparinum for use as a host cell organism for the expression of homologous and heterologous genes.Type: ApplicationFiled: January 19, 2001Publication date: October 25, 2001Inventors: Hongsheng Su, Zhongqi Shao, Ana Lydia Tkalec, Francoise Blain, Joseph Zimmerman
-
Patent number: 6303331Abstract: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.Type: GrantFiled: June 5, 1995Date of Patent: October 16, 2001Assignees: Arch Development Corporation, The Regent of the University of MichiganInventors: Craig B. Thompson, Lawrence H. Boise, Gabriel Nuñez
-
Patent number: 6297031Abstract: E. coli strains derived form E. coli strain VNIIgenetika 472t23 and obtained by a process involving transduction by bacteriophage P1 which bears a transposon which inactivates threonine dehydrogenase activity and isolation of a transductant lacking threonine dehydrogenase activity are useful for producing L-threonine.Type: GrantFiled: June 22, 2000Date of Patent: October 2, 2001Assignee: Ajinomoto Co., Inc.Inventors: Vladimir Georgievich Debabov, Jury Ivancvich Kozlov, Evgeny Mciseevich Khurges, Vitaly Arkadievich Livshits, Nelli Isaakovna Zhdanova, Mikhail Markovich Gusyatiner, Alexandr Konstantinovich Sokolov, Tatyana Alexandrovna Bachina, Nikolai Kazimirovich Yankovsky, Jury Dmitrievich Tsygankov, Andrei Jurievich Christoserdov, Tatyana Grigorievna Plotnikova, Irina Clegovna Shakalis, Alla Valentinovna Belareva, Raisa Alexandrovna Arsatiants, Albert Fedorovich Sholin, Tamara Mikhailovna Pozdnyakova
-
Patent number: 6274147Abstract: A system for the generation of live, nonpathogenic infectious pancreatic necrosis virus (IPNV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic transcripts derived from cloned DNA has been developed. Independent full-length cDNA clones were constructed which contained the coding and non-coding regions of RNA segments A and B of IPNV, respectively. Segment A was modified to prevent the expression of NS protein. Synthetic RNAs of both segments were produced by in vitro transcription of linearized plasmids with T7 RNA polymerase. Transfection of CHSE cells with combined plus-sense transcripts of both segments generated infectious virus. The development of a system for producing NS protein deficient IPNV will greatly facilitate studies of viral pathogenesis, and the development of live attenuated vaccines for IPNV.Type: GrantFiled: March 31, 1999Date of Patent: August 14, 2001Assignee: University of Maryland-Biotechnology InstituteInventors: Vikram N. Vakharia, Kun Yao
-
Patent number: 6271034Abstract: The present invention provides a method for high frequency of allelic exchange in the slow-growing mycobacteria using in vitro generated specialized transducing mycobacteriophages, as well as the recombinant slow-growing mycobacteria generated using the disclosed method. A transducing mycobacteriophage of the present invention comprises a conditional mycobacteriophage containing an E. coli bacteriophage lambda cosmid inserted into a non-essential region of the mycobacteriophage, said cosmid containing a mutated DNA substrate which is homologous to a wildtype nucleic acid sequence of a slow-growing mycobacterium. When slow-growing mycobacteria infected with the conditional transducing phage are cultured under conditions wherein the conditional transducing phage does not replicate, the mutated DNA substrate is incorporated into the chromosomal DNA of the slow-growing mycobacteria by homologous recombination, thereby generating the recombinant slow-growing mycobacteria of the present invention.Type: GrantFiled: July 8, 1999Date of Patent: August 7, 2001Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Stoyan S. Bardarov, William R. Jacobs, Jr.
-
Patent number: 6248578Abstract: A system for generating recombinant, human parainfluenza virus, particularly infectious, recombinant, human parainfluenza virus type 3 (HPIV-3) is provided. In one embodiment, the system comprises a clone comprising a nucleotide sequence that encodes a full-length, positive sense, anti-genome of HPIV, and at least one support clone comprising a nucleotide sequence that encodes the HPIV P protein and the HPIV L protein. In another embodiment, the system further comprises a support clone which comprises a nucleotide sequence that encodes the HPIV NP protein. The present invention also provides a MAH clone which comprises a nucleotide sequence encoding the full-length, positive sense, anti-genome of HPIV-3. The clone also comprises an RNA polymerase promoter operatively linked to the HPIV-3 antigenome-encoding sequence. In a preferred embodiment, the clone further comprises a nucleotide sequence which encodes a ribozyme immediately downstream from the sequence encoding the HPIV-3 anti-genome.Type: GrantFiled: May 6, 1998Date of Patent: June 19, 2001Assignee: The Cleveland Clinic FoundationInventors: Amiya K. Banerjee, Michael A. Hoffman
-
Patent number: 6245504Abstract: The present invention is directed to isolated transducing phages, methods of isolating transducing phages, and methods of using transducing phages including, for instance, transferring at least one nucleic acid fragment from a donor microbe to a recipient microbe, and producing a secondary metabolite from a microbe. The transducing phages typically have a broad host range, and transduce microbes in the Order Actinomycetales, in particular in the Family Streptomycetaceae, including Streptomyces coelicolor, Streptomyces lividans, Streptomyces venezuelae, Streptomyces avermitilis, and Saccharopolyspora erythraea. The transducing phages can be specialized transducing phages or generalized transducing phages.Type: GrantFiled: May 25, 1999Date of Patent: June 12, 2001Assignee: The University of Georgia Research Foundation, Inc.Inventors: Janet Westpheling, Julie A. Burke
-
Patent number: 6165756Abstract: A bacterial strain of Escherichia coli BKIIM B-3996, a producer of L-threonine, containing a recombinant plasmid pVIC40 and deposited on Nov. 19, 1987 in the collection of microorganism cultures at the USSR Antiobiotics Research Institute under Reg. No. 1867.Type: GrantFiled: September 7, 1999Date of Patent: December 26, 2000Assignee: Ajinomoto Co., Inc.Inventors: Vladimir Georgievich Debabov, Jury Ivanovich Kozlov, Evgeny Moiseevich Khurges, Vitaly Arkadievich Livshits, Nelli Isaakovna Zhdanova, Mikhail Markovich Gusyatiner, Alexandr Konstantinovich Sokolov, Tatyana Alexandrovna Bachina, Nikolai Kazimirovich Yankovsky, Jury Dmitrievich Tsygankov, Andrei Jurievich Chistoserdov, Tatyana Grigorievna Plotnikova, Irina Clegovna Shakalis, Alla Valentinovna Belareva, Raisa Alexandrovna Arsatiants, Albert Fedorovich Sholin, Tamara Mikhailovna Pozdnyakova
-
Patent number: 6159738Abstract: A fermentation process for producing succinic acid is provided comprising selecting a bacterial strain that does not produce succinic acid in high yield, disrupting the normal regulation of sugar metabolism of said bacterial strain, and combining the mutant bacterial strain and selected sugar in anaerobic conditions to facilitate production of succinic acid. Also provided is a method for changing low yield succinic acid producing bacteria to high yield succinic acid producing bacteria comprising selecting a bacterial strain having a phosphotransferase system and altering the phosphotransferase system so as to allow the bacterial strain to simultaneously metabolize different sugars.Type: GrantFiled: April 28, 1998Date of Patent: December 12, 2000Assignee: University of ChicagoInventors: Mark I. Donnelly, Cynthia Sanville-Millard, Ranjini Chatterjee
-
Patent number: 6159728Abstract: A delivery system, especially for delivery to targeted sites in the human or animal body, comprises capsids of the coat protein amino acid sequence of phage MS-2 or related phage, or a modification thereof which retains capsid-forming capability, and at least some of the capsids enclosing a moiety foreign to the genome of MS-2 or related phage.Type: GrantFiled: January 24, 1995Date of Patent: December 12, 2000Assignee: BTG International LimitedInventors: Peter George Stockley, Robert Allan Mastico
-
Patent number: 6150170Abstract: A method for introducing and expressing genes in animal cells is disclosed comprising infecting said animal cells with live invasive bacteria, wherein said bacteria contain a eukaryotic expression cassette encoding said gene. The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense RNA or a catalytic RNA.Type: GrantFiled: July 30, 1998Date of Patent: November 21, 2000Assignee: University of Maryland at BaltimoreInventors: Robert J. Powell, George K. Lewis, David M. Hone
-
Patent number: 6090629Abstract: A method for producing gene targeting constructs in bacterial by way of homologous recombination between bacterial phage and plasmids.Type: GrantFiled: October 31, 1997Date of Patent: July 18, 2000Assignee: Amgen, Inc.Inventor: Richard Woychik
-
Patent number: 6017732Abstract: Repertoires of first specific binding pair (sbp) members wherein each first sbp member has a chemical moiety bound covalently at an amino acid residue within the binding site are made and may be displayed at the surface of an organism such as a bacteriophage. Methods of making such repertoires may involve the provision of a population of encoding nucleic acid molecules wherein a codon encoding a selectively or preferentially modifiable amino acid is introduced in the region encoding the binding site, for instance by mutation or gene construction. First sbp member (e.g. antibodies) wherein binding to second sbp member (e.g. antigen) is enhanced in or dependent on the presence of the chemical moiety in the binding site may be selected from the repertoires.Type: GrantFiled: September 4, 1997Date of Patent: January 25, 2000Assignee: Medical Research CouncilInventors: Laurent Stephane Anne Therese Jespers, Gregory Paul Winter, Timothy Peter Bonnert, Thomas Martin Simon
-
Patent number: 5932426Abstract: The invention refers to a molecular presentation system in which viral proteins are foreseen as carriers for heterologous amino acid sequences. Hereby, the viral protein is derived from small insect viruses, primarily from Flock House Virus (FHV), with a known 3-dimensional structure and amino acid sequence, whereby heterologous amino acid sequences, for example epitopes, are inserted in the outwardly directed loops of the viral capsid protein. Moreover, the expression of the FHV capsid protein in insect cells can produce mature virus like particles (VLP) through a recombinant baculovirus.Type: GrantFiled: March 31, 1997Date of Patent: August 3, 1999Assignee: International Centre For Genetic Engineering and Biotechnology TriesteInventors: Francesco Ernesto Baralle, Eduardo Scodeller, Sergio Tisminetzky
-
Patent number: 5889190Abstract: The present invention is directed to recombinant plant viral nucleic acids and to hosts infected thereby. The recombinant plant viral nucleic acids comprise a native plant viral subgenomic promoter, at least one non-native plant viral subgenomic promoter, a plant viral coat protein coding sequence, and optionally, at least one non-native nucleic acid sequence to be transcribed or expressed in the infected host plant. The recombinant plant viral nucleic acids are stable, capable of systemic infection and capable of stable transcription or expression in the plant host of the non-native nucleic acid sequences.Type: GrantFiled: June 7, 1995Date of Patent: March 30, 1999Assignee: Biosource Technologies, Inc.Inventors: Jon Donson, William O. Dawson, George L. Grantham, Thomas H. Turpen, Ann Myers Turpen, Stephen J. Garger, Laurence K. Grill
-
Patent number: 5889191Abstract: A novel method of over expressing genes in plants is provided. This method is based on the RNA amplification properties of plus strand RNA viruses of plants. A chimeric multicistronic gene is constructed containing a plant promoter, viral replication origins, a viral movement protein gene, and one or more foreign genes under control of viral subgenomic promoters. Plants containing one or more of these recombinant RNA transcripts are inoculated with helper virus. In the presence of helper virus recombinant transcripts are replicated producing high levels of foreign gene RNA.Sequences are provided for the high level expression of the enzyme chloramphenicol acetyltransferase in tobacco plants by replicon RNA amplification with helper viruses and movement protein genes derived from the tobamovirus group.Type: GrantFiled: June 7, 1995Date of Patent: March 30, 1999Assignee: Biosource Technologies, Inc.Inventor: Thomas H. Turpen
-
Patent number: 5889268Abstract: A portable, hand-held reader reads a symbol associated with a product selected by a customer. A database of a host computer stores attribute data of many products. The database is accessed on a real-time basis to automatically retrieve the stored product attribute data. The retrieved data is displayed on a display associated with the reader. A card reading device is provided on the hand-held reader, for charging a customer's account, all at one location. A printer prints a written memorandum of the transaction.Type: GrantFiled: June 17, 1997Date of Patent: March 30, 1999Assignee: Symbol Technologies, Inc.Inventor: Jerome Swartz
-
Patent number: 5880273Abstract: This invention relates to an isolated and purified DNA encoding an amino acid sequence which comprises SEQ. ID. NO:3.Type: GrantFiled: June 30, 1997Date of Patent: March 9, 1999Assignee: Suntory LimitedInventors: Hideki Adachi, Masafumi Tsujimoto, Hiroyuki Arai, Keizo Inoue
-
Patent number: 5877159Abstract: A method for introducing and expressing genes in animal cells is disclosed comprising infecting said animal cells with live invasive bacteria, wherein said bacteria contain a eukaryotic expression cassette encoding said gene. The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense RNA or a catalytic RNA.Type: GrantFiled: May 3, 1995Date of Patent: March 2, 1999Assignee: University of Maryland at BaltimoreInventors: Robert J. Powell, George K. Lewis, David M. Hone